RAB25 and ovarian carcinoma: Specifically, Rab25 mediates invasive migratory phenotypes by directing the localization of integrin-recycling vesicles to the plasma membrane via the association with α5β1 integrins, resulting in increased cell motility in A2780 human ovarian cancer cells [23].